Arthritis a painful burden according to new report

February 4, 2014

Arthritis and other musculoskeletal conditions cost Australia $55.1 billion but only $4 million is spent on clinical trials, a new report shows.

A new into the scope of musculoskeletal (MSK) in Australia has revealed that, relative to the burden of arthritis and other MSK conditions on the Australian community, national funding for research is disproportionately low.

The report, led by Professor Rachelle Buchbinder, from Monash University's Department of Epidemiology and Preventive Medicine and the Cabrini Institute shows that despite and MSK conditions affecting 6.1 million people (26.9 per cent of the Australian population), research is severely underfunded.

Funded by Arthritis and Osteoporosis Victoria (A&OV), The scope, funding and publication of musculoskeletal clinical trials performed in Australia (2009 - 2013) report published in the Medical Journal of Australia, found that despite the rising cost of MSK conditions in Australia - $55.1 billion in 2012 – only $4 million was spent on clinical trials in the same year.

The findings suggest an urgent need for greater investment to provide relief to the 6.1 million Australians who live in pain from MSK conditions.

Professor Buchbinder noted that the $55.1 billion cost to the Australian community is only projected to rise as the population ages.

"Timely research that addresses important questions relevant to consumers, clinicians and policymakers and reduces the sizeable delays in translating evidence into practice is critical for reducing the burden associated with these conditions," Professor Buchbinder said.

In the last five years, the National Health and Medical Research Council (NHMRC) has awarded 29 project grants (and over $17.6 million) in support of Australian MSK trials. While this may seem like a lot, it actually works out to be .8 per cent of the total NHMRC grants (29 out of 3,631 or $17.6 million out of $354 million).

A&OV CEO, Linda Martin said the findings of this report were a cause for great concern for the millions of Australians living with MSK conditions.

"Not only is this a massive health problem, this is an ever-increasing medical bill that Australia's economy can no longer afford to pay. We need to work harder and work together to find solutions," Ms Martin said.

A recent report by Arthritis and Osteoporosis Victoria found that 58 per cent of Australians currently living with MSK are between 25 and 64 years – the prime working age.

Explore further: MSK ultrasound volume increase higher among non-radiologists, study suggests

More information: "The scope, funding and publication of musculoskeletal clinical trials performed in Australia." Allison M Bourne, Samuel L Whittle, Bethan L Richards, Chris G Maher and Rachelle Buchbinder. Med J Aust 2014; 200 (2): 88-91. DOI: 10.5694/mja13.10907

Related Stories

MSK ultrasound volume increase higher among non-radiologists, study suggests

February 1, 2012
Between 2000 and 2009, the musculoskeletal (MSK) ultrasound volume increase among non-radiologists was much higher than that among radiologists, according to a study in the February issue of the Journal of the American College ...

Low back pain world's highest contributor to disability, study finds

December 14, 2012
(Medical Xpress)—Low back pain is the highest contributor to disability in the world, according to a pivotal international study released today.

New report on complementary therapies for arthritis reveals lack of scientific evidence

January 10, 2013
(Medical Xpress)—A new report written by a senior lecturer from the University of Aberdeen into the effectiveness of the complementary therapies that are commonly used for treating arthritis and other musculoskeletal conditions ...

Chronic diseases taking up more of GPs' time

November 19, 2013
GPs in Australia are working three hours less per week in direct clinical care, however they are dealing with more health problems per visit, research led by the University of Sydney shows.

Confectionery sales a Halloween horror story

October 21, 2013
Halloween may constitute a serious public health risk to Australian children, according to an article published today in the Medical Journal of Australia.

Recommended for you

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

Osteoarthritis could be prevented with good diet and exercise

May 12, 2017
Osteoarthritis can potentially be prevented with a good diet and regular exercise, a new expert review published in the Nature Reviews Rheumatology reports.

Rodents with trouble walking reveal potential treatment approach for most common joint disease

May 11, 2017
Maintaining the supply of a molecule that helps to nourish cartilage prevented osteoarthritis in animal models of the disease, according to a report published in Nature Communications online May 11.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

chiefsfan37
not rated yet Feb 04, 2014
This is an interesting article, but I'm curious; has anyone here looked into topical pain relief to fight arthritis pain? It provides prescription strength pain relief without any pills or side effects. A family member of mine gets topical pain gels through a pharmacy in the midwest, A&R Pharmacy in Liberty, MO, and all he does is apply the gel whenever he's in pain. He has had significant results since going this route and I highly recommend it for anyone struggling with pain and/or pills. I hope this helps!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.